Gokaldas Exports Logs 9 Sequential Revenue Increase in Q4 Driven by Operational Efficiencies
Indian Commerce Minister Piyush Goyal to Lead 150Member Business Delegation to Canada to Strengthen Trade Ties
EU Fines Temu 200 Million for Failing to Curb Sale of Illegal and Unsafe Products
IRS Settlement Blocks Tax Audits on Trump and Family Businesses
Irans Strait of Hormuz Threat Sparks Oil Market Jitters Analysts Warn of Supply Risks
UltraRich in Germany Control Over 25 of Financial Wealth BCG Report Reveals
FBNC Q1 2026 Earnings Slight EPS Beat Amid Stable Performance
GLPI Q1 2026 Earnings EPS Misses Estimates as Revenue Remains Unreported
Lightspeed Commerce Q1 2026 Earnings EPS Misses Estimates Despite Positive Stock Reaction
HTLD Q1 2026 Earnings NarrowerThanExpected Loss Surprises Markets
Bolt Biotherapeutics Q1 2026 Earnings WiderThanExpected Loss Amid PreRevenue Stage
Brookfield Infrastructure Partners LP Q1 2026 Earnings Steep EPS Miss Pressures Stock
BRC Group Holdings Notes Edge Higher Amid Mixed FixedIncome Sentiment
Cal Redwood Acquisition Corp Right CRAQR Holds Steady Near Support as SPAC Rights Trade Flat
CarPartscom PRTS Holds Steady Near Support Level After Modest Gain
CUBB Holds Steady Near Key Levels Amid Minimal Price Movement
Neuberger Energy Infrastructure Fund NML Pulls Back Testing Key Support Levels
Meta May Enter Cloud Computing Market Zuckerberg Suggests
MRTN Q1 2026 Earnings EPS Beats Estimates by 1765 Shares Edge Higher
International Flavors Fragrances IFF Holds Near 75 as Flat Session Suggests Consolidation
PDS Biotechnology Q1 2026 Earnings EPS Beat Highlights Progress Despite PreRevenue Status
NKE Q1 2026 Earnings Strong EPS Beat Amidst Uncertain Revenue Landscape
APTV Q1 2026 Earnings EPS Beats Estimates Amid Solid Operational Performance
Daily Journal Corp Q4 2025 Earnings Strong EPS of 3061 Reported Amid Flat Stock Reaction
CHE Q1 2026 Earnings EPS Beats Estimates by 55
ONE Gas Inc OGS Q1 2026 Earnings EPS Misses Estimates Yet Shares Edge Higher
ESLA Q1 2026 Earnings EPS Misses Estimates by Wide Margin as ClinicalStage Biotech Continues RD Spending